[Form 4] Crescent Capital BDC, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Crescent Capital BDC, Inc. (CCAP) reported an insider share purchase by its Chief Financial Officer on a Form 4. On 11/17/2025, the CFO bought 2,000 shares of common stock in an open market transaction coded as a purchase.

The weighted average purchase price was $13.3415 per share, with individual trades executed between $13.34 and $13.3499. After this transaction, the CFO beneficially owned 34,284 shares of CCAP common stock.

This total includes 2,627 shares acquired during 2025 through dividend reinvestment that had not been previously reported. The filing notes that full trade price details are available to regulators, the company, or any security holder upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lombard Gerhard

(Last) (First) (Middle)

11100 SANTA MONICA BLVD

SUITE 2000

(Street)

LOS ANGELES CA 90025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crescent Capital BDC, Inc. [ CCAP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/17/2025	11/17/2025	P		2,000	A	$13.3415(1)	34,284(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.3499, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

2. Includes 2,627 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

	/s/ Gerhard Lombard	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CCAP report in this Form 4?

Crescent Capital BDC, Inc. (CCAP) reported that its Chief Financial Officer purchased 2,000 shares of CCAP common stock in an open market transaction on 11/17/2025.

Who is the insider involved in this CCAP Form 4 filing and what is their role?

The reporting person is an officer of Crescent Capital BDC, Inc., serving as Chief Financial Officer, and filed the Form 4 as a single reporting person.

At what price did the CCAP CFO buy the 2,000 shares?

The Form 4 states a weighted average purchase price of $13.3415 per share, with individual trades executed between $13.34 and $13.3499.

How many CCAP shares does the CFO own after this transaction?

Following the reported purchase, the CFO beneficially owns 34,284 shares of Crescent Capital BDC, Inc. common stock, held as direct ownership.

What is the significance of the 2,627 CCAP shares from dividend reinvestment?

The filing explains that the total holdings include 2,627 shares acquired in 2025 through dividend reinvestment, which had not been previously reported under Rule 16a-11.

What is the purpose of a Form 4 for CCAP insiders?

Form 4 is used by CCAP insiders, such as directors or officers, to report acquisitions or dispositions of company securities and their resulting beneficial ownership.